logo
Plus   Neg
Share
Email

Sanofi Appoints Novartis Executive Paul Hudson As CEO

French drug giant Sanofi SA (SNYNF,SNY) said Friday that it appointed Paul Hudson, 51 years, as its Chief Executive Officer, to succeed Olivier Brandicourt who has decided to retire.

Paul Hudson, who most recently was Chief Executive Officer of Novartis Pharmaceuticals and Member of the Executive Committee of Novartis, will replace Brandicourt on September 1, 2019.

Paul Hudson spent his 28-years career with major pharmaceutical companies such as Schering Plough, Astra Zeneca and Novartis. He will move to Paris.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Shares of Stage Stores, Inc. (SSI) hit a new 52-week high of $6.74 today, which is a giant leap forward for a stock that was perilously close to delisting just a few months ago. The stock has been experiencing positive momentum, after raising expectations for fiscal 2019. Amazon founder and Chief Executive Jeff Bezos said his company will continue to support the U.S. Department of Defense, noting that the U.S. will be in "big trouble" if big technology companies stop working with the Pentagon. "We are going to support the Department of Defense, this country is important," Bezos said at the annual Reagan National Defense Forum in Simi Valley, California. Surly Bikes recalled 5,139 units of Surly front bicycle racks for possible crash and injury hazards, a statement by the U.S. Consumer Product Safety Commission showed. The company said the front bicycle rack can loosen and contact the front wheel, resulting in crash and injury hazards to the rider.The recall involves Surly 8-pack racks and Surly 24-pack front bicycle racks and Pack Rat bicycles.
Follow RTT
>